Genetic Variation (CHRNA5), Medication (Combination Nicotine Replacement Therapy vs. Varenicline) and Smoking Cessation()

OBJECTIVE: Recent evidence suggests that the efficacy of smoking cessation pharmacotherapy can vary across patients based on their genotypes. This study tests whether the coding variant rs16969968 in the CHRNA5 nicotinic receptor gene predicts the effects of combination nicotine replacement therapy...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Drug Alcohol Depend
Main Authors: Chen, Li-Shiun, Baker, Timothy B., Jorenby, Douglas, Piper, Megan, Saccone, Nancy, Johnson, Eric, Breslau, Naomi, Hatsukami, Dorothy, Carney, Robert M., Bierut, Laura J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4537319/
https://ncbi.nlm.nih.gov/pubmed/26142345
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drugalcdep.2015.06.022
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados